iShares Biotechnology ETF $IBB Stake Cut by North Star Investment Management Corp.

North Star Investment Management Corp. reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 15.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,263 shares of the financial services provider’s stock after selling 225 shares during the period. North Star Investment Management Corp.’s holdings in iShares Biotechnology ETF were worth $160,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Ramirez Asset Management Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth about $26,000. Financial Gravity Asset Management Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth about $30,000. Woodside Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth about $31,000. CX Institutional purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth about $32,000. Finally, Garde Capital Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 1st quarter worth about $36,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 1.4%

IBB opened at $140.96 on Friday. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $150.04. The business has a 50-day moving average of $137.83 and a 200-day moving average of $129.56.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were given a dividend of $0.0828 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.